Pressalit Care is a leader in furnishings for people with physical disabilities. They develop, manufacture and market solutions for installation in kitchens and bathrooms in nursing homes, hospitals as well as private homes. In 1996, Pressalit Care introduced their products as 3D AutoCAD models to the market and they were among the so-called "first movers" in the field. Pressalit Care decided to cooperate with BIMobject® since the popularity for BIM is increasing. BIMobject® is the game changer in the building industry and offers objects that contains all necessary information that is required to be able to create an accomplished project. Pressalit Care's ambition is to build their entire product range as BIM objects, thereby provide clients, architects, engineers and other planners the best tools for planning. The value added for the users on the portal is that they don't have to create these advanced objects themselves since Pressalit Care offers flexible design solutions, the BIM objects are parametrical and includes more information than a regular object. This additional information is required to be able to adjust the object according to individual needs. Pressalit Care believes it is advantageous for BIM users to have access to building components from many different industries and suppliers via a single portal - and thereof the cooperation with BIMobject®. The objects are available for Revit. Follow the link to explore and download the objects for free: http://bimobject.com/Product?Manufacturer=pressalit "We are proud to offer BIM objects within the healthcare sector. This is a new market for us and we gladly welcome this type of manufacturer to the BIMobject® Portal. Today we get a lot of requests from hospitals building projects and Pressalit Cares BIM objects will be a great asset for our users. The objects contains a range of information and are nicely designed objects which will create great custom value for the users", says Alexander Steen, Nordic Business Manager at BIMobject®. About Pressalit Care: Pressalit Cares mission is to compensate for physical limitations to the greatest possible extent. They are aiming to improve the quality of life of the physically disabled, to enhance healthcare workers working environments and to provide a better and long-term solution for the managers responsible for investment. For more than 35 years, the keep living philosophy has been a guiding principle for Pressalit Care's development of flexible kitchen and bathroom solutions for people with disabilities. Thanks to its research-based knowledge, Pressalit Care is a market leader within specialist kitchen and bathroom solutions and today provides consultancy to customers worldwide. An underlying respect for the individual and his or her possibilities is also reflected in the company's relationship to society at large and the local community. At Pressalit, Corporate Social Responsibility (CSR) is deeply rooted in the company's strategy and values and guides all parts of the organisation. Pressalit Care's head office is located in Denmark. About BIMobject®: BIMobject® is a game changer for the construction industry worldwide with its cloud based Portal offering development, maintenance and syndication of digital replicas - BIM objects - of manufactured building and interior products. The marketing and pre-sales services associated with the Portal are channelled and integrated, through specialised software, into CAD/BIM applications to create a business-to-business communication across the globe. Manufacturers use BIMobject® to promote and deliver their products directly into BIM processes enabling their products to be selected and generate a real improvement in sales. http://bimobject.com/ BIMobject® - Winner for the Red Herring Europe Top 100 Award 2013, Winner for the 2013 Red Herring 100 Global Award and Winner of the IAIR EUROPEAN AWARDS 2013! BIMobject AB - a public company listed on NASDAQ OMX First North: Share Ticker: BIM Certified Advisor: Sedermera Fondkommission This is an English version of a press release communicated by BIMobject®. In any case of doubt or possible differences regarding the different versions it is the Swedish version that shall apply. [HUG#1835114]
Pressalit Care launch products within the healthcare as BIM
Top 10 Most Recent News Articles
Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026
A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...
Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss
Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...
Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake
Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...
Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control
Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...
Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data
Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...
Continue Reading
Uber Data Breach: Class Action Investigation Begins
When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...
Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives
Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...
Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle
IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...
Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path
New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...
Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit
High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...
Continue ReadingTop 5 Most Recently Viewed Articles
Sandler Partners Unveils 2025 Superstar Trip Destination
Sandler Partners Unveils 2025 Superstar Trip Destination Sandler Partners is thrilled to reveal the highly anticipated location for its 2025 Superstar Trip, a special reward designed to honor Partners who have excelled in achieving their growth objectives for the year. The trip will take place at the stunning Susurros del Corazón Resort, located along the picturesque...
Continue Reading
e.l.f. Beauty Stock Insights: Understanding Market Trends Today
Market Sentiment Surrounding e.l.f. Beauty Investors with substantial capital are showing a cautious approach towards e.l.f. Beauty (NYSE: ELF). This sentiment isn't just noise in the market; it reflects deeper strategies that should be on the radar of traders and analysts alike. There has been significant insight gleaned from public options activity which suggests that...
Continue Reading
Empowering Teens Through Free AI Bootcamp by Mark Cuban
Empowering Teens Through Innovative AI Bootcamp Time is of the essence for high school students eager to launch their careers in technology with the Mark Cuban Foundation's Artificial Intelligence (AI) Bootcamp. Hosted by Girls Inc., this remarkable initiative opens doors for teens interested in the cutting-edge realm of AI. Applications for participation are set to close...
Continue Reading
BlackRock's Major Acquisition of Global Infrastructure Partners
BlackRock Secures $12.5 Billion Deal The U.S. Federal Energy Regulatory Commission has recently approved BlackRock's substantial acquisition of Global Infrastructure Partners, valued at $12.5 billion. This approval is a pivotal moment for BlackRock as it seeks to broaden its reach within the infrastructure investment sector. Details of the Acquisition In this significant...
Continue Reading
Key Analyst Initiations Impacting Major Stocks This Week
Recent Analyst Initiations: An Overview In the dynamic realm of stock trading, the insights of analysts can have a major impact on market trends. Recently, Wall Street has made significant adjustments to their ratings for several well-known stocks. Below, we summarize the latest analyst actions that may affect investor decisions this week. Arm Holdings plc (NASDAQ: ARM)...
Continue Reading